678 related articles for article (PubMed ID: 11472623)
1. Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody.
Alwayn IP; Xu Y; Basker M; Wu C; Buhler L; Lambrigts D; Treter S; Harper D; Kitamura H; Vitetta ES; Abraham S; Awwad M; White-Scharf ME; Sachs DH; Thall A; Cooper DK
Xenotransplantation; 2001 Aug; 8(3):157-71. PubMed ID: 11472623
[TBL] [Abstract][Full Text] [Related]
2. An exploratory investigation of the effect of arsenic trioxide on anti-Gal antibody production in baboons.
Gollackner B; Ryan D; Knosalla C; Basker M; Alwayn IP; Harper D; Salomon G; Mauiyyedi S; Correa L; Thall A; Cooper DK
Xenotransplantation; 2003 Jan; 10(1):80-7. PubMed ID: 12535229
[TBL] [Abstract][Full Text] [Related]
3. Anti-Gal(alpha)1-3Gal antibody response to porcine bone marrow in unmodified baboons and baboons conditioned for tolerance induction.
Kozlowski T; Monroy R; Xu Y; Glaser R; Awwad M; Cooper DK; Sachs DH
Transplantation; 1998 Jul; 66(2):176-82. PubMed ID: 9701260
[TBL] [Abstract][Full Text] [Related]
4. Depletion of anti-gal antibodies in baboons by intravenous therapy with bovine serum albumin conjugated to gal oligosaccharides.
Teranishi K; Gollackner B; Bühler L; Knosalla C; Correa L; Down JD; White-Scharf ME; Sachs DH; Awwad M; Cooper DK
Transplantation; 2002 Jan; 73(1):129-39. PubMed ID: 11792992
[TBL] [Abstract][Full Text] [Related]
5. Pig kidney transplantation in baboons: anti-Gal(alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation.
Bühler L; Yamada K; Kitamura H; Alwayn IP; Basker M; Appel JZ; Colvin RB; White-Scharf ME; Sachs DH; Robson SC; Awwad M; Cooper DK
Transplantation; 2001 Dec; 72(11):1743-52. PubMed ID: 11740383
[TBL] [Abstract][Full Text] [Related]
6. Failure to deplete anti-Galalpha1-3Gal antibodies after pig-to-baboon organ xenotransplantation by immunoaffinity columns containing multiple Galalpha1-3Gal oligosaccharides.
Mañez R; Domenech N; Centeno A; Lopez-Pelaez E; Crespo F; Juffe A; Duthaler RO; Katopodis AG
Xenotransplantation; 2004 Sep; 11(5):408-15. PubMed ID: 15303977
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo investigation of a novel monoclonal antibody to plasma cells (W5 mAb).
Harper D; Gollackner B; Xu Y; Calderhead D; Ryan D; Li W; Cheng J; Wu C; Moran K; Latinne D; Bazin H; White-Scharf ME; Cooper DK; Awwad M
Xenotransplantation; 2004 Jan; 11(1):78-90. PubMed ID: 14962296
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a new humanized anti-CD20 monoclonal antibody, IMMU-106, and Its use in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphoma.
Stein R; Qu Z; Chen S; Rosario A; Shi V; Hayes M; Horak ID; Hansen HJ; Goldenberg DM
Clin Cancer Res; 2004 Apr; 10(8):2868-78. PubMed ID: 15102696
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice.
DiLillo DJ; Hamaguchi Y; Ueda Y; Yang K; Uchida J; Haas KM; Kelsoe G; Tedder TF
J Immunol; 2008 Jan; 180(1):361-71. PubMed ID: 18097037
[TBL] [Abstract][Full Text] [Related]
10. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response.
Bühler L; Awwad M; Basker M; Gojo S; Watts A; Treter S; Nash K; Oravec G; Chang Q; Thall A; Down JD; Sykes M; Andrews D; Sackstein R; White-Scharf ME; Sachs DH; Cooper DK
Transplantation; 2000 Jun; 69(11):2296-304. PubMed ID: 10868629
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of four CD22 antibodies as ricin A chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomas.
Shen GL; Li JL; Ghetie MA; Ghetie V; May RD; Till M; Brown AN; Relf M; Knowles P; Uhr JW
Int J Cancer; 1988 Nov; 42(5):792-7. PubMed ID: 3263328
[TBL] [Abstract][Full Text] [Related]
12. In vivo immunoadsorption of antipig antibodies in baboons using a specific Gal(alpha)1-3Gal column.
Taniguchi S; Neethling FA; Korchagina EY; Bovin N; Ye Y; Kobayashi T; Niekrasz M; Li S; Koren E; Oriol R; Cooper DK
Transplantation; 1996 Nov; 62(10):1379-84. PubMed ID: 8958260
[TBL] [Abstract][Full Text] [Related]
13. Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption.
Kozlowski T; Shimizu A; Lambrigts D; Yamada K; Fuchimoto Y; Glaser R; Monroy R; Xu Y; Awwad M; Colvin RB; Cosimi AB; Robson SC; Fishman J; Spitzer TR; Cooper DK; Sachs DH
Transplantation; 1999 Jan; 67(1):18-30. PubMed ID: 9921791
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic immunosuppressive therapy and extracorporeal immunoadsorption in the suppression of anti-alphaGal antibody in the baboon.
Lambrigts D; Van Calster P; Xu Y; Awwad M; Neethling FA; Kozlowski T; Foley A; Watts A; Chae SJ; Fishman J; Thall AD; White-Scharf ME; Sachs DH; Cooper DK
Xenotransplantation; 1998 Nov; 5(4):274-83. PubMed ID: 9915255
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
[TBL] [Abstract][Full Text] [Related]
16. Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies.
Behr TM; Wörmann B; Gramatzki M; Riggert J; Gratz S; Béhé M; Griesinger F; Sharkey RM; Kolb HJ; Hiddemann W; Goldenberg DM; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3304s-3314s. PubMed ID: 10541379
[TBL] [Abstract][Full Text] [Related]
17. Plasma perfusion by apheresis through a Gal immunoaffinity column successfully depletes anti-Gal antibody: experience with 320 aphereses in baboons.
Watts A; Foley A; Awwad M; Treter S; Oravec G; Buhler L; Alwayn IP; Kozlowski T; Lambrigts D; Gojo S; Basker M; White-Scharf ME; Andrews D; Sachs DH; Cooper DK
Xenotransplantation; 2000 Aug; 7(3):181-5. PubMed ID: 11021663
[TBL] [Abstract][Full Text] [Related]
18. Influence of cytotoxicity enhancers in combination with human serum on the activity of CD22-recombinant ricin A against B cell lines, chronic and acute lymphocytic leukemia cells.
van Horssen PJ; van Oosterhout YV; Evers S; Backus HH; van Oijen MG; Bongaerts R; de Witte T; Preijers FW
Leukemia; 1999 Feb; 13(2):241-9. PubMed ID: 10025898
[TBL] [Abstract][Full Text] [Related]
19. Homodimers but not monomers of Rituxan (chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemotherapeutic agent and an immunotoxin.
Ghetie MA; Bright H; Vitetta ES
Blood; 2001 Mar; 97(5):1392-8. PubMed ID: 11222385
[TBL] [Abstract][Full Text] [Related]
20. The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide.
Ashton-Chess J; Meurette G; Karam G; Petzold T; Minault D; Naulet J; Tesson L; Plat M; Anegon I; Soulillou JP; Blancho G
Xenotransplantation; 2004 Mar; 11(2):112-22. PubMed ID: 14962273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
